Coyote Ventures

Coyote Ventures is a venture capital firm focused on early-stage investments in women’s health and wellness startups. Founded in 2021 by Jessica Karr, the firm aims to address the significant underinvestment in women’s health, a market estimated to exceed $1 trillion globally. Coyote Ventures backs innovative consumer and digital health companies, particularly those solving problems that disproportionately affect women and underserved populations. With a portfolio that includes companies like Wile (hormonal wellness), Hera Biotech (endometriosis diagnostics), and Flex (cycle care), Coyote Ventures is building a synergistic pipeline in the rapidly growing femtech sector. The firm’s investment strategy prioritizes founders with deep expertise and lived experience, ensuring solutions are both impactful and practical. Additionally, all of the portfolio companies have female CEOs, with many co-founders being BIPOC or LGBTQ+. Coyote Ventures’ inaugural fund has attracted backing from prominent investors, including Bank of America, The Case for Her, and Tripple Family Office, solidifying its position as a key player in the health and wellness investment space. By championing women-led innovations, Coyote Ventures aims to drive systemic change in how healthcare is designed and delivered for women.